| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/23/1998 | DE19701619A1 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome |
| 07/23/1998 | CA2278424A1 Process for preparing indane-like compounds |
| 07/23/1998 | CA2278153A1 Secreted proteins and polynucleotides encoding them |
| 07/23/1998 | CA2277924A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 07/23/1998 | CA2277869A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 07/23/1998 | CA2277480A1 Paroxetine compositions |
| 07/22/1998 | EP0854191A2 Human cardiac/brain tolloid-like protein |
| 07/22/1998 | EP0854146A1 Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders |
| 07/22/1998 | EP0854140A2 Vitronectin receptor antagonists, their production and their use |
| 07/22/1998 | EP0853673A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 07/22/1998 | EP0853661A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 07/22/1998 | EP0853626A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 07/22/1998 | EP0853621A1 Novel substituted azacyclic or azabicyclic compounds |
| 07/22/1998 | EP0853619A1 Disubstituted piperidine derivatives |
| 07/22/1998 | EP0853617A1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 07/22/1998 | EP0853616A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853615A1 Piperidine compounds as calcium channel blockers |
| 07/22/1998 | EP0853614A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors |
| 07/22/1998 | EP0853476A2 Pharmaceutical preparation containing nimesulide for topical use |
| 07/22/1998 | EP0766695B1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 07/22/1998 | EP0736025B1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht1d antagonistic activity |
| 07/22/1998 | EP0725775B1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands |
| 07/22/1998 | EP0698014B1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists |
| 07/22/1998 | EP0677042B1 Selective ligands of 5ht1d-5ht1b receptors derived from indole-piperazine useful as medicaments |
| 07/22/1998 | EP0630893B1 N,n'-disubstituted amide derivative |
| 07/22/1998 | EP0575613B1 Use of the amino acid glycine for the preparation of a medicament with antistress-, stress-preventive and nootropic action |
| 07/22/1998 | EP0557385B1 Topical compositions for transdermal delivery of produg derivatives of morphine |
| 07/22/1998 | EP0415999B1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
| 07/22/1998 | CN1188407A New pharmaceutical composition with anaesthetic effect |
| 07/22/1998 | CN1188111A 4-hydroxy-piperidine derivatives |
| 07/22/1998 | CN1187994A Durg for curing headache and preparation technology thereof |
| 07/21/1998 | US5783590 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz CD!indoles |
| 07/21/1998 | US5783587 Psychological and brain disorders |
| 07/21/1998 | US5783583 Nalmefene, withdrawal from drug dependence, side effect reduction |
| 07/21/1998 | US5783579 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists |
| 07/21/1998 | US5783574 Imidazolylakyl derivatives of imidazo 5,1-c! 1,4!benzoxazin-1-one process for their preparation |
| 07/21/1998 | US5783572 Treatment of neurodegenerative disorders |
| 07/21/1998 | US5783199 Anaesthetic mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane |
| 07/17/1998 | CA2227132A1 Pharmaceutical compounds |
| 07/16/1998 | WO1998030707A2 Eukaryotic gene expression cassette and uses thereof |
| 07/16/1998 | WO1998030706A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | WO1998030693A2 Tumor necrosis factor receptor 5 |
| 07/16/1998 | WO1998030683A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/16/1998 | WO1998030561A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart |
| 07/16/1998 | WO1998030227A1 Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 07/16/1998 | WO1998030220A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/16/1998 | WO1998030219A1 Method for treatment of cns-involved lysosomal storage diseases |
| 07/16/1998 | CA2278326A1 Eukaryotic gene expression cassette and uses thereof |
| 07/16/1998 | CA2277582A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 07/16/1998 | CA2276720A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart |
| 07/16/1998 | CA2272941A1 Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
| 07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853085A1 Piperidine derivatives having anxiolytic effect |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 07/15/1998 | EP0852585A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/15/1998 | EP0852497A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 07/15/1998 | EP0852496A1 Method for treating a tic disorder |
| 07/15/1998 | EP0852495A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 07/15/1998 | EP0852494A2 Peripherally active anti-hyperalgesic opiates |
| 07/15/1998 | EP0681477A4 Genetic modification of neural stem cells. |
| 07/15/1998 | EP0528926B1 Soluble peptide analogues containing binding sites |
| 07/15/1998 | CN1187769A Lactacystin analogs |
| 07/15/1998 | CN1187768A Combination of 5-HT uptake inhibitor with selective 5-HT1A antagonist |
| 07/15/1998 | CN1039126C Tachiquinine antagonist tricyclic compounds and pharmaceutical compositions containing such compounds |
| 07/14/1998 | US5780632 Imide derivatives and their production and use |
| 07/14/1998 | US5780600 Purified ciliary neurotrophic factor |
| 07/14/1998 | US5780512 Alkylated (hetero) cyclic compounds |
| 07/14/1998 | US5780510 2,4-disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals |
| 07/14/1998 | US5780501 Treatment method using anti-neurodegeneratively active 10-aminoaliphatyl-dibenz b,f!oxepines |
| 07/14/1998 | US5780500 Anti-neurodegeneratively active 10-aminoaliphatyl-dibenzi b,f! oxepines |
| 07/14/1998 | US5780495 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/14/1998 | US5780487 S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide |
| 07/14/1998 | US5780486 Administering to treat diabetic neuropathy, migraine, neurogenic inflammation or rheumatoid arthitis |
| 07/14/1998 | US5780484 Promoting repair of neuronal damage caused by disease of injury |
| 07/14/1998 | US5780475 Having reduced side effects |
| 07/14/1998 | US5780474 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds |
| 07/14/1998 | US5780467 Morpholine compounds are prodrugs useful as tachykinin receptor antagonists |
| 07/14/1998 | US5780461 Therapeutic treatment of cancer with Protein Kinase C inhibitors |
| 07/14/1998 | US5780460 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 07/14/1998 | US5780449 Oligonucelotides; nucleotide sequences |
| 07/14/1998 | US5780436 Peptide compositions with growth factor-like activity |
| 07/14/1998 | US5780046 Administering in combination with an acidic component to improve taste |
| 07/14/1998 | CA2158130C Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
| 07/14/1998 | CA2135752C Use of (e)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of alzheimer's disease |
| 07/14/1998 | CA2041113C Thienobenzodiazepine derivatives and their use as pharmaceuticals |
| 07/14/1998 | CA2026118C Use of a trimethyl-1,3,7 xanthine derivative for the tratment of the memory disturbances and cognitive deficits of aging and alzheimer's disease |
| 07/09/1998 | WO1998029566A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029430A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | WO1998029415A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 07/09/1998 | WO1998029413A1 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS |
| 07/09/1998 | WO1998029411A1 Sulfonamide compounds having 5-ht receptor activity |
| 07/09/1998 | WO1998029407A2 N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
| 07/09/1998 | WO1998005780A3 Voltage-gated calcium channel antagonist and methods |
| 07/09/1998 | DE3590035C2 Synergistic analgesic and antiinflammatory compsn. |
| 07/09/1998 | CA2278340A1 Novel human apoptosis regulator |
| 07/09/1998 | CA2278031A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | CA2276610A1 3-aryl substituted pyrazolo¬4,3-d|pyrimidine derivatives; corticotropin-releasing factor receptor (crf1) specific ligands |